Abstract
Eleven patients with malignant trophoblastic neoplasia, six with choriocarcinoma and five with hydatidiform mole (three of them with invasive mole) were treated with methotrexate at a dose of 17.5–25 mg/daily for 2 to 5 days in repeat courses. One patient who was previously treated by hysterectomy for choriocarcinoma had no evidence of active growth at the onset of chemotherapy, but subsequently died. The remaining ten patients all had disseminated tumor and four of them exhibited signs of brain involvement. Eight patients responded by complete tumor regression and have remained free of disease on followup from 5 to 40 months. One patient died from disease and another from drug toxicity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1967 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Hsu, CT., Wang, TF., Liang, SE., Hsu, HP., Tsai, WT., Pen, SY. (1967). The Effect of Methotrexate in Trophoblastic Diseases. In: Holland, J.F., Hreshchyshyn, M.M. (eds) Choriocarcinoma. UICC Monograph Series, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85907-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-85907-6_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85909-0
Online ISBN: 978-3-642-85907-6
eBook Packages: Springer Book Archive